These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9652872)

  • 1. Nifedipine after acute myocardial infarction--sola dosis facit venenum: only the dose determines the harm.
    Messerli FH
    Cardiovasc Drugs Ther; 1998 May; 12(2):149-50. PubMed ID: 9652872
    [No Abstract]   [Full Text] [Related]  

  • 2. Nifedipine trials.
    Rafflenbeul W
    Circulation; 1996 Apr; 93(7):1473-4. PubMed ID: 8641042
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium channel blocker debate: true lies?
    Leor J; Battler A
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):413-5. PubMed ID: 8924054
    [No Abstract]   [Full Text] [Related]  

  • 4. Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction.
    Jonas M; Goldbourt U; Boyko V; Mandelzweig L; Behar S; Reicher-Reiss H
    Cardiovasc Drugs Ther; 1998 May; 12(2):177-81. PubMed ID: 9652876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nifedipine in ischemic heart disease: a ban on its use or a differential approach to therapy?].
    Martsevich SIu
    Ter Arkh; 1996; 68(9):31-5. PubMed ID: 9005608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-substitution of nifedipine slow-release preparations.
    Van Veenhuyzen D; Coetzee R
    S Afr Med J; 2002 Nov; 92(11):838, 840. PubMed ID: 12506575
    [No Abstract]   [Full Text] [Related]  

  • 7. [Calcium antagonists. The prevention of a recurrent myocardial infarct and sudden death].
    Mazur NA; Vasil'eva NN; Pavlova TS; Kul'ginskaia IV; Zhdanova SM
    Ter Arkh; 1992; 64(9):50-3. PubMed ID: 1481155
    [No Abstract]   [Full Text] [Related]  

  • 8. [Calcium antagonists--much noise about nothing?].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1995 Dec; 18(12):344-9. PubMed ID: 8569586
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA gives calcium channel blockers clean bill of health but warns of short-acting nifedipine hazards.
    Marwick C
    JAMA; 1996 Feb; 275(6):423-4. PubMed ID: 8627948
    [No Abstract]   [Full Text] [Related]  

  • 10. Risks and benefits of calcium antagonists.
    Lichtlen PR
    Lancet; 1995 Oct; 346(8980):962. PubMed ID: 7564741
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced proteinuria after cessation of long-acting, osmotic release nifedipine GITS in diabetic nephropathy.
    Hess B
    Nephrol Dial Transplant; 1997 Aug; 12(8):1772-3. PubMed ID: 9269678
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group.
    Kanamasa K; Kimura A; Miyataka M; Takenaka T; Ishikawa K
    Cancer; 1999 Mar; 85(6):1369-74. PubMed ID: 10189144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged QT interval and ventricular fibrillation after treatment with sublingual nifedipine for malignant hypertension.
    Peters FP; de Zwaan C; Kho L
    Arch Intern Med; 1997 Dec 8-22; 157(22):2665-6. PubMed ID: 9531240
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium channel blockers in systemic hypertension.
    Frishman WH; Charlap S; Michelson EL
    Am J Cardiol; 1986 Jul; 58(1):157-60. PubMed ID: 3524178
    [No Abstract]   [Full Text] [Related]  

  • 15. [Calcium antagonists: safe or unsafe?].
    Rosendaal FR; Psaty BM; Furberg CD
    Ned Tijdschr Geneeskd; 1996 Apr; 140(17):916-8. PubMed ID: 8676969
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of calcium antagonists on long-term prognosis of patients with myocardial infarction].
    Novikova NA
    Kardiologiia; 2002; 42(3):62-3. PubMed ID: 12494189
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the safety of short-acting nifedipine in children with hypertension.
    Egger DW; Deming DD; Hamada N; Perkin RM; Sahney S
    Pediatr Nephrol; 2002 Jan; 17(1):35-40. PubMed ID: 11793132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers for the management of preterm birth: a review.
    Nassar AH; Aoun J; Usta IM
    Am J Perinatol; 2011 Jan; 28(1):57-66. PubMed ID: 20640972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine.
    King JF; Flenady V; Papatsonis D; Dekker G; Carbonne B
    Aust N Z J Obstet Gynaecol; 2003 Jun; 43(3):192-8. PubMed ID: 14712983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
    Ishikawa K; Nakai S; Takenaka T; Kanamasa K; Hama J; Ogawa I; Yamamoto T; Oyaizu M; Kimura A; Yamamoto K; Yabushita H; Katori R
    Circulation; 1997 May; 95(10):2368-73. PubMed ID: 9170398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.